Home
Circassia

Circassia Market Share Analysis for May 2026

Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management.

Health > Biotechnology and Pharmaceuticals

Domaincircassia.com

Year Founded2006

Employees201 - 500

Annual Revenue$25M - $50M

Circassia

Circassia (including company regionals)

circassia.com

See more website traffic and engagement information

Circassia Revenue up to May 2026 is 25M - 50M

revenue generated by Circassia top domains

Circassia top domains revenue over 3 years

Revenue for Circassia top domains

circassia.com25M - 50M

See more with Sales Intelligence

Total visits to Circassia's top domains

Understand Circassia market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Circassia's top domains

Analyze Circassia engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Circassia's top domains

See how Circassia keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Circassia top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Circassia

These are the website technologies, by industry, used by Circassia top domains

Advertising (2)

DoubleClick

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

Recruitment (2)

Applicant Pro

More Technologies

10

See all

News & Signals from Circassia

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCircassia Pharmaceuticals plc launched Niox Vero nasal mode in Europe for screening the primary ciliary dyskinesia on Sep 1st '17.UK based company, Circassia launched Niox Vero nasal mode in Europe for screening the primary ciliary dyskinesia in September 2017.

NewsCircassia Pharmaceuticals plc hired Garry Watts as senior independent director on Mar 2nd '20.Circassia Pharmaceuticals PLC ( LON:CIR ), a specialty pharmaceutical company focused on respiratory disease, has confirmed the proposed appointment of Garry Watts to the Board as a senior independent director with effect from 2 March 2020.

NewsCircassia Pharmaceuticals plc hires Michael Roller as chief financial officer.Circassia also announced the appointment of Michael Roller as chief financial officer to replace Julien Cotta, who has stepped down after eight years in the role.